Copyright
©The Author(s) 2003.
World J Gastroenterol. Oct 15, 2003; 9(10): 2300-2307
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2300
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2300
Table 9 Hepatobiliary manifestations in IBD patients
| Total n (%) | PSC n (%) | Small duct PSC n (%) | NAFLD/NASH n (%) | |
| Ulcerative colitis | ||||
| Total (n = 619) | 77* (12.4) | 10 (1.6) | 8 (1.3) | 58 (9.4) |
| Male (n = 317) | 39 (12.3) | 3 (1.0) | 6 (1.9) | 30 (9.5) |
| Female (n = 302) | 38* (12.6) | 7 (2.3) | 2 (0.7) | 28 (9.3) |
| Crohn’s disease | ||||
| Total (n = 254) | 57 (22.4) | 2 (0.8) | 6 (2.4) | 49 (19.3) |
| Male (n = 125) | 27 (21.6) | 2 (1.6) | 6 (4.8) | 19 (15.2) |
| Female (n = 129) | 30 (23.3) | 0 | 0 | 30 (23.3) |
- Citation: Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study. World J Gastroenterol 2003; 9(10): 2300-2307
- URL: https://www.wjgnet.com/1007-9327/full/v9/i10/2300.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i10.2300